What causes elevated High-Density Lipoprotein (HDL) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated HDL Levels (117 mg/dL)

Extremely high HDL cholesterol levels (>100 mg/dL) may paradoxically increase cardiovascular mortality risk despite HDL typically being considered "good cholesterol." 1

Primary Causes of Elevated HDL

  • Genetic factors are a common cause of extremely high HDL levels, including inherited variations in genes regulating HDL metabolism 2
  • Female sex hormones can contribute to higher HDL levels, as women typically have higher HDL than men (optimal levels are 2.4 mmol/L or 93 mg/dL for women versus 1.9 mmol/L or 73 mg/dL for men) 1
  • Certain medications can significantly raise HDL levels:
    • Niacin (most potent HDL-raising agent available) 3
    • Fibrates (moderate HDL-raising effect) 3
    • Estrogen therapy 3

Secondary Causes and Lifestyle Factors

  • Regular aerobic exercise can increase HDL cholesterol levels 4
  • Moderate alcohol consumption may raise HDL levels, though this is not recommended solely for HDL benefits 4
  • Dietary factors that can increase HDL:
    • Omega-3 fatty acids 3
    • Monounsaturated fat consumption 4
    • Low-carbohydrate diets in some individuals 4

Clinical Significance of HDL of 117 mg/dL

  • U-shaped mortality curve: Both extremely high and low HDL levels are associated with increased mortality risk 1
  • For men, HDL levels of 2.5-2.99 mmol/L (97-115 mg/dL) are associated with 36% higher all-cause mortality compared to optimal levels 1
  • For women, HDL levels ≥3.5 mmol/L (≥135 mg/dL) are associated with 68% higher all-cause mortality compared to optimal levels 1

Evaluation of Elevated HDL

  • Complete lipid profile should be assessed to evaluate overall cardiovascular risk, including:
    • LDL cholesterol (primary target of therapy) 4
    • Triglycerides (evaluate for potential mixed dyslipidemia) 4
    • Non-HDL cholesterol (total cholesterol minus HDL cholesterol) 4, 5
  • Assess for metabolic syndrome components, as elevated HDL may mask other cardiovascular risk factors 4
  • Evaluate TG/HDL ratio as a marker of cardiovascular risk beyond individual lipid measurements 6

Clinical Implications

  • Do not focus solely on the high HDL value - evaluate the entire lipid profile and overall cardiovascular risk 4, 6
  • Consider genetic testing if there is a family history of extreme lipid abnormalities or premature cardiovascular disease 7
  • Monitor for paradoxical cardiovascular risk despite the traditionally "protective" view of HDL 1, 8
  • Evaluate for secondary causes of altered lipid metabolism, including medications, alcohol consumption, and endocrine disorders 5

Treatment Considerations

  • No specific treatment is indicated to lower HDL in the absence of other lipid abnormalities 4, 6
  • Focus on managing other cardiovascular risk factors if present (hypertension, diabetes, smoking) 6
  • If other lipid abnormalities exist, treat according to established guidelines focusing on LDL as the primary target 4
  • Consider specialist referral for patients with extreme HDL elevations (>100 mg/dL) for further evaluation 7

References

Research

High-density lipoproteins: biochemical and metabolic factors.

The American journal of cardiology, 1983

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mixed Hypercholesterolemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Triglyceride to HDL Ratio Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

High-density lipoproteins (HDL): Novel function and therapeutic applications.

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.